{
  "anumber": "A73235174",
  "id": "A73235174_0007",
  "page_index": 7,
  "resources": {
    "full_jpg": "https://dctn4zjpwgdwdiiy5odjv7o2se0bqgjb.lambda-url.us-east-1.on.aws/iiif/3/og-2023-kc-nara_A73235174_0007/full/max/0/default.jpg"
  },
  "fields": {
    "doctype": {
      "ms_doctype_v1": "form"
    },
    "form_title": {
      "ms_form_title_llm_v1": "CHOLESTEROL RECOMMENDED REFERENCE RANGES, STATE OF FL. NO 800001824"
    },
    "years": {
      "ms_years_nlp_v1": [
        2023,
        1991
      ]
    }
  },
  "is_g325a": false,
  "is_cert_naturalization": false,
  "full_text": "Screened by NARA, 7/31/2023 CHOLESTEROL RECOMMENDED REFERENCE RANGES The panol on detection evaluation and treatment of high blood chalesteral in adults has been charged by the National In stitute of Health (NIH) with development of practical guidelines for clinicians for measurement assessment and treat ment of high blood cholesterol levela in adult patient Thai panel has developed the following reporting guidalines (our points) for classification of the patient Recommendations of the Adult Treatment Panel of the National Cholesterol Education Program for Classification of Patients Total Cholesterol Risk Classification in blood LDL Cholesterol Desirable < 200 mg/dL <130mg/dL Borderline high 200-239mg/dL 130-159mg/dL High a 240mg/dL >160mg/dL SERUM IRON TIBC AND PER CENT SATURATION IN VARIOUS CONDITIONS Serum Fe TIBCOPY Saturation (ug/dL) (ug/dL) (Per Cent) Normal 60-150 300-260 20-50 PRO Iron deficiency Chronic infections Malignancy Menstruation N Iron poisoning Hemolytic anemia Var Var Var Hemochromatosis N. Myocardial infarction N Late pregnancy Oral contraceptives Viral hepatitis N.1 Nephrosis Kwashlorkor Var Thalassemia = decrease | = increase N = normal Var = variable TIBC Local Iron-binding capacity Clinical and Diagnosis Management 18th Edition Revised 1991 By Laboratory Methods John Bernard Henry, M.D. STATE OF FL. NO 800001824 MEDICARE PROVIDER NO. L-8613"
}